Abstract
A 79-year-old male with follicular thyroid carcinoma metastasizing to the lung, bone and lymph nodes was subjected to whole-body scintigraphy using technetium-99m tetrofosmin and99mTc-sestamibi. Both agents delineated the metastatic lesions and the two image qualities were comparable. We believe that99mTc-tetrofosmin and99mTc-sestamibi images may be helpful in localizing metastatic foci and substitute for thallium-201 in the follow-up of patients with differentiated thyroid carcinoma.
This is a preview of subscription content, log in via an institution to check access.
References
Tonami N, Hisada K. Thallium-201 scintigraphy in postoperative detection of thyroid cancer.Radiology 1980; 136: 461–464.
Hoefnagel CA, Delprat CC, Marcuse HR, de Vijlder JJM. Role of thallium-201 total-body scintigraphy in follow-up of thyroid carcinoma.J Nucl Med 1986; 27: 1854–1857.
Brendel AJ, Guyot M, Jeandot R, Lefort G, Manciet G. Thallium-201 imaging in the follow-up of differentiated thyroid carcinoma.J Nucl Med 1988; 29: 1515–1520.
David Charkes N, Vitti RA, Brooks K. Thallium-201 SPECT increases detectability of thyroid cancer metastases.J Nucl Med 1990; 31: 147–153.
Iida Y, Hidaka A, Hatabu H, Kasagi K, Konishi J. Follow-up study of postoperative patients with thyroid cancer by thallium-201 scintigraphy and serum thyroglobulin measurement.J Nucl Med 1991; 32: 2098–2100.
Hassan IM, Sahweil A, Constantinidis C, Mahmoud A, Nair M, Omar YT, Abdel-Dayen H. Uptake and kinetics of Tc-99m-hexakis 2-methoxy isobutyl isonitrile in benign and malignant lesions in the lungs.Clin Nucl Med 1989; 14: 333–340.
O'Driscoll CM, Baker F, Casey MJ, Duffy GJ. Localization of recurrent medullary thyroid carcinoma with technetium-99m-methoxyisobutylisonitrile scintigraphy: a case report.J Nucl Med 1991; 32: 2281–2283.
O'Doherty MJ, Kettle AG, Well P, Collins REC, Coakley AJ. Parathyroid imaging with technetium-99m-sestamibi: preoperative localization and tissue uptake studies.J Nucl Med 1992; 33: 313–318.
Taillefer R, Boucher Y, Potvin C, Lambert R. Detection and localization of parathyroid adenomas in patients with hyperparathyroidism using a single radionuclide imaging procedure with technetium-99m-sestamibi (double-phase study).J Nucl Med 1992; 33: 1801–1807.
Caner B, Kitapci M, Unlu M, etal. Technetium-99m-MIBI uptake in benign and malignant bone lesions: a comparative study with technetium-99m-MDP.J Nucl Med 1992; 33: 319–324.
Scott AM, Kostakoglu L, O'Brien JP, Straus DJ, Abdel-Dayem HM, Larson SM. Comparison of technetium-99m MIBI and thallium-201-chloride uptake in primary thyroid lymphoma.J Nucl Med 1992; 33: 1396–1398.
LeBouthillier G, Morais J, Picard M, Picard D, Chartrand R, D'Amour P. Tc-99m sestamibi and other agents in the detection of metastatic medullary carcinoma of the thyroid.Clin Nucl Med 1993; 18: 657–661.
Kao CH, Wang SJ, Lin WK, Hsu CY, Liao SQ, Yeh SH. Differentiation of single solid lesions in the lungs by means of single-photon emission tomography with technetium-99m-methoxyisobutylisonitrile.Eur J Nucl Med 1993; 20: 249–254.
Shin WJ, Kadzielawa K, Lee C, Moody EB, Ryo UK. Tc-99m sestamibi uptake by cerebellar metastasis from bronchogenic carcinoma.Clin Nucl Med 1993; 18: 887–890.
O'Tuama LA, Troves ST, Lanar JN, etal. Thallium-201 versus technetium-99m-MIBI SPECT in evaluation of childhood brain tumours: a within-subject comparison.J Nucl Med 1993; 34: 1045–1051.
Park CH, Kim SM, Zhang JJ, Intenzo CM, McEwan JR. Tc-99m MIBI brain SPECT in the diagnosis of recurrent glioma.Clin Nucl Med 1994; 19: 57–58.
Kostakoglu L, Roistacher N, Kalaigian H, Larson SM, Abdel-Dayem H. Simultaneous gallium-67 citrate and technetium-99m sestamibi SPET in a case of myocardial lymphoma: comparison with echocardiography before and after chemotherapy.Eur J Nucl Med 1994; 21: 1013–1016.
Chin ML, Kronauge JF, Piwnica-Worms D. Effect of mitochondrial and plasma membrane potentials on accumulation of hexakis (2-methoxyisobutylisonitrile) technetium(I) in cultured mouse fibroblast.J Nucl Med 1990; 31: 1646–1653.
Rao VV, Chiu ML, Kronauge JF, Piwnica-Worms D. Expression of recombinant human multidrug resistance P-glycoprotein in insect cells confers decreased accumulation of technetium-99m-sestamibi.J Nucl Med 1994; 35: 510–515.
Higley B, Smith FW, Smith T, etal. Technetium-99m-1,2-bis(bis(2-ethoxyethyl)phosphino) ethane: human biodistribution, dosimetry and safety of a new myocardial perfusion imaging agent.J Nucl Med 1993; 34: 30–38.
Kelly JD, Forster AM, Higley B, etal. Technetium-99m-tetrofosmin as a new radiopharmaceutical for myocardial perfusion imaging.J Nucl Med 1993; 34: 222–227.
Gerson MC, Lukes J, Deutsch E, etal. Comparison of technetium-99m-Q3 and thallium-201 for detection of coronary artery disease in humans.J Nucl Med 1994; 35: 580–586.
Rossetti C, Vanoli G, Paranelli G, etal. Human biodistribution, dosimetry and clinical use of technetium(III)-99m-Q12.J Nucl Med 1994; 35: 1571–1580.
Fagret D, Marie PY, Brunotte F, etal. Stress and delayed SPECT myocardial imaging with a new neutral technetium-99m nitrido dithiocarbamate complex (TcN-NOET): comparison with thallium-201 SPECT imaging and coronary angiography [abstract].J Nucl Med 1994; 35: 114.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kosuda, S., Yokoyama, H., Katayama, M. et al. Technetium-99m tetrofosmin and technetium-99m sestamibi imaging of multiple metastases from differentiated thyroid carcinoma. Eur J Nucl Med 22, 1218–1220 (1995). https://doi.org/10.1007/BF00800609
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00800609